Vandetanib versus gefitinib in patients with advanced non-small-cell lung cancer: results from a two-part, double-blind, randomized phase ii study (Q46068556)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Vandetanib versus gefitinib in patients with advanced non-small-cell lung cancer: results from a two-part, double-blind, randomized phase ii study |
scientific article |
Statements
1 reference
Vandetanib versus gefitinib in patients with advanced non-small-cell lung cancer: results from a two-part, double-blind, randomized phase ii study (English)
1 reference
Ronald B Natale
1 reference
David Bodkin
1 reference
Ramaswamy Govindan
1 reference
Bethany G Sleckman
1 reference
Naiyer A Rizvi
1 reference
Adolfo Capó
1 reference
Paul Germonpré
1 reference
Wilfried E E Eberhardt
1 reference
Paul K Stockman
1 reference
Sarah J Kennedy
1 reference
Malcolm Ranson
1 reference
30 March 2009
1 reference
27
1 reference
15
1 reference
2523-2529
1 reference